From: An evaluation of the preprints produced at the beginning of the 2022 mpox public health emergency
Study design | Study | Publication status | Selection (/3 or /4) | Comparability (/2) | Outcomea (/2 or /3) | Total score (/7 or /9) | Risk of biasb |
---|---|---|---|---|---|---|---|
Case-control | Yinka-Ogunleye [17] | Preprint | 3/4 | 2 | 2/3 | 7/9 | Medium |
Published | 3/4 | 2 | 2/3 | 7/9 | Medium | ||
Cross-sectional | Preprint | 1/3 | 0 | 2/2 | 3/7 | High | |
Published | 1/3 | 2 | 2/2 | 5/7 | High | ||
Preprint | 0/3 | 0 | 2/2 | 2/7 | High | ||
Published | 1/3 | 0 | 2/2 | 3/7 | High | ||
Preprint | 1/3 | 0 | 2/2 | 3/7 | High | ||
Published | 1/3 | 2 | 2/2 | 5/7 | High | ||
Preprint | 0/3 | 2 | 2/2 | 4/7 | High | ||
Published | 1/3 | 2 | 2/2 | 5/7 | High | ||
Preprint | 0/3 | 0 | 2/2 | 2/7 | High | ||
Published | 0/3 | 0 | 2/2 | 2/7 | High | ||
Preprint | 0/3 | 2 | 2/2 | 4/7 | High | ||
Published | 0/3 | 2 | 1/2 | 3/7 | High | ||
Preprint | 0/3 | 2 | 2/2 | 4/7 | High | ||
Published | 0/3 | 2 | 2/2 | 4/7 | High | ||
Cohort | Preprint | 2/4 | 0 | 2/3 | 4/9 | High | |
Published | 2/4 | 0 | 3/3 | 5/9 | High | ||
Arbel [32] | Unpublished preprint | 3/4 | 2 | 1/3 | 6/9 | Medium | |
Preprint | 3/4 | 2 | 3/3 | 8/9 | Low | ||
Published | 3/4 | 2 | 3/3 | 8/9 | Low |